Alton L. Boynton, Ph.D

EX-10.10 11 v11186exv10w10.txt EXHIBIT 10.10 Exhibit 10.10 FIRST AMENDMENT TO NORTHWEST BIOTHERAPEUTICS, INC. LOAN AGREEMENT, SECURITY AGREEMENT AND 10% CONVERTIBLE, SECURED PROMISSORY NOTE THIS FIRST AMENDMENT TO NORTHWEST BIOTHERAPEUTICS, INC. LOAN AGREEMENT, SECURITY AGREEMENT AND 10% CONVERTIBLE, SECURED PROMISSORY NOTE (the "First Amendment") is made and entered into as of July 26, 2005, by and among NORTHWEST BIOTHERAPEUTICS, INC., a Delaware corporation (the "Maker") and Toucan Capital Fund II, L.P. (the "Holder"). This First Amendment amends the Note (as defined below). RECITALS A. Section 17.6 of that certain Northwest Biotherapeutics, Inc. Loan Agreement, Security Agreement and 10% Convertible, Secured Promissory Note, in the principal amount of $500,000.00 dated as of October 22, 2004, by and between the Maker and the Holder in the form attached to this First Amendment as Exhibit A (the "Note"), states that any provision of such note may be amended or waived in writing by the Holder and the Maker; and B. The Maker and the Holder wish to amend the Note as provided below. AGREEMENT NOW, THEREFORE, in consideration of these premises and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows: 1. Section 1 of the Note is hereby amended to provide that the Maturity Date is November 1, 2005. 2. All other terms and conditions of the Note shall be unaffected hereby and remain in full force and effect. 1 3. This First Amendment shall be governed by and construed under the laws of the state of Delaware without giving effect to principles of conflicts of laws of the State of Delaware or any other state. [SIGNATURE PAGE FOLLOWS] 2 IN WITNESS WHEREOF, the parties hereto have executed this FIRST AMENDMENT TO NORTHWEST BIOTHERAPEUTICS, INC. LOAN AGREEMENT, SECURITY AGREEMENT AND 10% CONVERTIBLE, SECURED PROMISSORY NOTE as of the date first above written. MAKER: NORTHWEST BIOTHERAPEUTICS, INC., a Delaware corporation By:_________________________________ Name:_______________________________ Title:______________________________ HOLDER: Toucan Capital Fund II, L.P. By:________________________________ Linda Powers, Managing Director 3